Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C. - Wikidata - awgldk - TriplyDB

Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.

Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.

http://www.wikidata.org/entity/Q34170220

about

Safety of pediatric HIV elimination: the growing population of HIV- and antiretroviral-exposed but uninfected infants Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11)Asking the right questions: developing evidence-based strategies for treating HIV in women and children EUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associations Surveillance monitoring for safety of in utero antiretroviral therapy exposures: current strategies and challenges.Drug safety evaluation of oral tenofovir disoproxil fumarate-emtricitabine for pre-exposure prophylaxis for human immunodeficiency virus infection.Antiretroviral therapy, pregnancy, and birth defects: a discussion on the updated data.Changes in Fertility at the Population Level in the Era of ART in Rural Malawi.Risk factors of HIV-1 vertical transmission (VT) and the influence of antiretroviral therapy (ART) in pregnancy outcome.Incidence of pregnancy after initiation of antiretroviral therapy in South Africa: a retrospective clinical cohort analysis.Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants Birth defects in a cohort of infants born to HIV-infected women in Spain, 2000-2009.CLEFT PALATE IN HIV-EXPOSED NEWBORNS OF MOTHERS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY.In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States.Pregnancy outcomes in women with advanced HIV infection in Italy.First trimester exposure to antiretroviral therapy and risk of birth defects In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothers Zidovudine use in pregnancy and congenital malformations.Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.Cancer Among Children With Perinatal Exposure to HIV and Antiretroviral Medications--New Jersey, 1995-2010.British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review).Tolerance of the newborn to antiretroviral drug exposure in utero.Efavirenz-based antiretroviral therapy versus nevirapine-including regimens for prevention of mother-to-child transmission of HIV option B plus in resource-limited settings: is there anything missing?Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis.Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.Treating women with HIV: is it different than treating men?Cardiac Effects of Highly Active Antiretroviral Therapy in Perinatally HIV-Infected Children: The CHAART-2 Study.British HIV Association guidelines for the management of HIV infection in pregnant women 2012 Trends in Neonatal Prophylaxis and Predictors of Combination Antiretroviral Prophylaxis in US Infants from 1990 to 2015

P2860

Q28538275-BF8EB93D-AE71-4DEC-A17E-9328E2E8BD52 Q28538279-0C8605CB-8340-4C5B-AD51-E910DA03544E Q28743488-47089C6E-4E7C-44E9-9648-E86D5FB42BB9 Q28817912-8B27AAE6-C236-4E21-B001-4A75D3DF1493 Q30244368-9170E236-AD7D-4E16-B475-C8EBF02C9791 Q30249113-46B5BBD6-6FCA-4EF8-80AC-6ACA3B46B78B Q30661395-6B500D0C-4BC5-42C9-AEB7-407F7F7078E7 Q33832976-4496B85E-6462-41D3-9798-70315654129A Q33859660-CB5FD9E7-9920-49DC-80DE-04652A4DEDAF Q34331885-28C38C54-8C61-4DA8-9963-3B9360458694 Q34860149-72718B63-4427-4B60-A839-D801C616D770 Q34979228-42096078-9CD2-41A4-944B-7F83CC8CED1C Q35038144-9C7717F3-821A-4D5D-96C0-AA5BF1B0EEF3 Q35075011-D57E10A2-EC90-46EC-9D5D-43FD81BC2E73 Q35445035-810AC4B3-8463-404A-8821-5A47659AEF06 Q35572618-392DBCA3-5E63-4DF0-8236-FE06686B18FE Q35594678-FDA69EFF-C950-47C8-AFFB-1D959F8A2918 Q35680819-C42EFEA1-1D48-419B-BE42-9EA1A0C91D39 Q36077016-336F9780-7385-4741-861A-034E96B09E3C Q36379162-2188862B-1C53-4680-ABB1-345117C0BB1B Q36438846-0923845C-2D1D-4AC0-B061-F73823155264 Q37326056-07643183-FCFE-4CA7-BA2C-F7A66361AD75 Q38325427-EAEEFE5E-F744-4AAE-81B9-636FBFF6F1F2 Q38366365-7BD9B354-1A5C-4C38-A5E3-3744B344B9FA Q38630880-26344898-07A9-49F7-A6D8-BE9E1FF6ADAC Q38861593-5750A109-AB5C-4BB5-8D9C-6D83742F3B42 Q38909409-DCC58491-2043-4B57-A0CD-B21EF3C13F60 Q42260917-95B423B8-5009-45DA-B56F-BED8C7FB6788 Q46341976-DDFB42E1-1C95-4A29-B1A9-C5290CE7354C Q47629689-CE0D2AAE-967D-49D7-88A2-D352D67DA4E8 Q57076282-BBF6EECA-39BE-4B36-97B6-3FE7E5025625 Q57826130-ED824C3A-53C1-4600-AB81-90ABC0083094

P2860

Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.

http://www.wikidata.org/entity/Q34170220

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Birth defects among children b ...... trials protocols 219 and 219C.

@ast

Birth defects among children b ...... trials protocols 219 and 219C.

@en

Birth defects among children b ...... trials protocols 219 and 219C.

@nl

type

label

Birth defects among children b ...... trials protocols 219 and 219C.

@ast

Birth defects among children b ...... trials protocols 219 and 219C.

@en

Birth defects among children b ...... trials protocols 219 and 219C.

@nl

prefLabel

Birth defects among children b ...... trials protocols 219 and 219C.

@ast

Birth defects among children b ...... trials protocols 219 and 219C.

@en

Birth defects among children b ...... trials protocols 219 and 219C.

@nl

P1433

Q34170220-E575F5E4-2803-4EB6-BFBB-AD48914636E5

P1476

Q34170220-5F898319-B9E3-4131-BACC-CEEA44AB9B60

P2093

Q34170220-0D0AEC44-9179-4F65-B340-356FC3911F77

Q34170220-19F13475-8344-44C3-97CF-9120565E8EE0

Q34170220-1B12E3B1-9A17-4050-BDBE-54BDF7218E49

Q34170220-3C8B77B5-3457-48EA-9495-89415BFA2875

Q34170220-423BC570-F08E-4910-AE8D-CD1C8D463B70

Q34170220-68F4F328-FE63-4722-A006-0C7BF9D3AF02

Q34170220-BEF111BB-D26E-46D2-9EAC-E622C3C76C48

Q34170220-E8582A52-F463-43CA-A815-0112258F4FE9

Q34170220-EBDBA35D-C199-4EEA-BECA-C321F18E9EDA

P2860

Q34170220-199B9C5A-709E-48B8-BC62-3DA02532AB1A

Q34170220-26AB40F7-E477-4993-84C0-9E4D5807A8EE

Q34170220-4398B5FD-9A56-4913-BECA-20B04E8E8B3F

Q34170220-4D4B00F7-2DCA-4D7E-B880-367950D25283

Q34170220-4E8F8674-5B47-467C-9D3A-39B0D870A4EA

Q34170220-5A54CE65-E9CD-4620-AB89-D5C932CD54DA

Q34170220-5D681CBD-D93E-49E7-ACF4-6BA20E104B08

Q34170220-5E1EC6D9-C45F-4D85-AE96-72D17D03AFB6

Q34170220-6FDCE511-461F-4444-A01F-FA739364073B

Q34170220-88D93AFF-44B3-4448-9D20-FC4B897C5D65

P304

Q34170220-E9AD309C-9235-4F90-A85D-7BEF95B582D7

P31

Q34170220-26F7CD17-4ADF-4D9D-A8D8-A325A8D9D79A

P356

Q34170220-FB32C29F-0DE6-44F4-8E56-96623885A5F8

P433

Q34170220-C5CF456A-CD42-4C6A-BD50-C3019D9A77F3

P478

Q34170220-70D63DFF-8DC4-4E9D-8FC0-0ABA470DECF9

P50

Q34170220-E26CCB9B-FB1F-40C3-8005-B075651BA753

P577

Q34170220-F3134DA4-88CA-4349-B17F-593BAD06B3E1

P5875

Q34170220-7DACC6DE-0BE2-4ADA-BBB1-1B75A81E5C16

P698

Q34170220-C73530CE-7ED2-44AE-9FEE-91706B8EB699

P932

Q34170220-77199C44-F8B4-4759-BA97-A308B4809583

P356

INF.0B013E3181E74A2F

P1433

Pediatric Infectious Disease Journal

P1476

Birth defects among children b ...... trials protocols 219 and 219C

@en

P2093

Coleen K Cunningham

http://www.w3.org/2001/XMLSchema#string

D Heather Watts

http://www.w3.org/2001/XMLSchema#string

Daniel Conway

http://www.w3.org/2001/XMLSchema#string

Hans Spiegel

http://www.w3.org/2001/XMLSchema#string

James Oleske

http://www.w3.org/2001/XMLSchema#string

Mark J Abzug

http://www.w3.org/2001/XMLSchema#string

Paige L Williams

http://www.w3.org/2001/XMLSchema#string

Rhoda S Sperling

http://www.w3.org/2001/XMLSchema#string

Russell B Van Dyke

http://www.w3.org/2001/XMLSchema#string

P2860

Is first trimester exposure to the combination of antiretroviral therapy and folate antagonists a risk factor for congenital abnormalities?

The incidence of congenital heart disease

Reporting birth defects surveillance data 1968-2003.

Myelomeningocele in an infant with intrauterine exposure to efavirenz.

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.

Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.

Prevalence of congenital cardiovascular malformations in children of human immunodeficiency virus-infected women: the prospective P2C2 HIV Multicenter Study. P2C2 HIV Study Group, National Heart, Lung, and Blood Institute, Bethesda, Maryland.

Mitochondrial disease in the offspring as a result of antiretroviral therapy.

In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.

Myelomeningocele in a child with intrauterine exposure to efavirenz.

P304

721-727

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/INF.0B013E3181E74A2F

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44664698

http://www.w3.org/2001/XMLSchema#string

P698

20539252

http://www.w3.org/2001/XMLSchema#string

P932

2948952

http://www.w3.org/2001/XMLSchema#string